Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Therapies

Cancer Therapies

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma.

BMC cancer·2026

Same author

Defining the Role of SABR in Head and Neck Cancer: Results From a Multi-institutional Delphi Consensus.

International journal of radiation oncology, biology, physics·2026

Same author

Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementation.

Trials·2026

Same author

Thermal Ablation and Rapid On-Site Cytology for Lung Nodules-A 'One-Stop Shop' Approach for Small Lesions: Experience in 8 Patients.

Journal of medical imaging and radiation oncology·2026

Same author

Impacts of a Group-Based Intervention To Mitigate Concurrent Chemotherapy and Radiotherapy-Induced Dysphagia: A Retrospective Cohort Study.

Dysphagia·2026

Same author

Quantitative Imaging Advances in HPV-Positive Oropharyngeal Carcinoma.

Cancers·2026

Search research articles

Related Experiment Video

Updated: Mar 21, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Radiotherapy and Immune System Interactions Historical Perspectives and Clinical Advancements.

Safiy Yahia¹, Ayman J Oweida², Houda Bahig³

¹Campus de Rimouski, Université Laval, Quebec City, Canada.

Molecular Carcinogenesis

|March 19, 2026

Summary

This summary is machine-generated.

Radiotherapy (RT) modulates the immune system, impacting cancer treatment. Understanding these complex interactions, including abscopal effects and fractionation, is key to optimizing RT efficacy and minimizing side effects for better patient outcomes.

Keywords:

fractionation immune system low‐dose irradiation lymphatic system radiotherapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

Related Experiment Videos

Last Updated: Mar 21, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

Area of Science:

Oncology
Immunology
Radiation Oncology

Background:

Radiotherapy (RT) is a cornerstone of cancer treatment, evolving from benign condition management.
RT significantly impacts the immune system, affecting various immune cell populations.
Understanding RT-immune interactions is crucial for enhancing therapeutic outcomes.

Purpose of the Study:

To review the complex interactions between RT and the immune system.
To explore emerging strategies for enhancing RT therapeutic outcomes.
To guide future RT practices by integrating historical insights and contemporary research.

Main Methods:

Review of historical and contemporary research on RT and the immune system.
Discussion of RT's effects on immune cells, fractionation, and abscopal effects.
Exploration of advancements like FLASH radiotherapy and immune-preserving approaches.

Main Results:

RT exerts diverse effects on immune cell populations.
Fractionation and abscopal effects play critical roles in modulating immune responses.
Emerging strategies and advancements aim to optimize RT's immunomodulatory potential.

Conclusions:

Personalized approaches, biomarker identification, and combination therapies are essential for maximizing RT efficacy.
Minimizing adverse effects while optimizing immunomodulatory potential is a key goal.
Future RT practices should integrate immune-modulating strategies for improved oncology outcomes.